NFKB1 and atherosclerosis: These findings reveal the regulatory function of Rnd3 within the TRAF6/NF‐κB/NLRP3 signaling cascade in ECs, highlighting the potential therapeutic value of targeting Rnd3 to combat atherosclerosis.